삼백초와 황금의 혼합 추출물을 유효성분으로 함유하는골다공증 예방 또는 치료용 조성물
    4.
    发明公开
    삼백초와 황금의 혼합 추출물을 유효성분으로 함유하는골다공증 예방 또는 치료용 조성물 无效
    含有麻醉中药和麻黄碱混合物的混合物的组合物用于预防或治疗骨质疏松症

    公开(公告)号:KR1020100009151A

    公开(公告)日:2010-01-27

    申请号:KR1020080069892

    申请日:2008-07-18

    CPC classification number: A61K36/539 A61K36/78 A61K2300/00

    Abstract: PURPOSE: A composition containing mixture extract of Saururus chinensis and Scutellaria baicalensis is provided to suppress osteoclast differentiation, enhance bone density and bone content, and prevent or treat osteoporosis. CONSTITUTION: A pharmaceutical composition for preventing or treating osteoporosis contains mixture extract of Saururus chinensis and Scutellaria baicalensis as an active ingredient. The weight ratio of the Saururus chinensis and Scutellaria baicalensis is 1:10-10:1. A food composition for preventing and relieving osteoporosis contains mixture extract of Saururus chinensis and Scutellaria baicalensis as an active ingredient. A method for producing the mixture extract comprises: a step of washing Saururus chinensis and Scutellaria baicalensis with water and drying; a step of extracting the Saururus chinensis and Scutellaria baicalensis with solvent; a step of cooling the extract at room temperature and filtering; a step of decompress-concentrating and freeze-drying; and a step of mixing the extract of Saururus chinensis and Scutellaria baicalensis.

    Abstract translation: 目的:提供含有Saururus chinensis和黄芩的混合物提取物的组合物,以抑制破骨细胞分化,增强骨密度和骨含量,并预防或治疗骨质疏松症。 构成:用于预防或治疗骨质疏松症的药物组合物含有中华黄牛和黄芩的混合物提取物作为活性成分。 中华黄牛和黄芩的重量比为1:10-10:1。 用于预防和缓解骨质疏松症的食物组合物含有中华黄芪和黄芩的混合物提取物作为活性成分。 制备混合物提取物的方法包括:用水洗涤中华黄芩和黄芩的步骤; 用溶剂萃取中华黄龙和黄芩的一步; 在室温下冷却提取物并过滤的步骤; 减压浓缩和冷冻干燥步骤; 并将中国黄芪和黄芩提取物混合在一起。

    삼백초 추출물 또는 이로부터 분리된 활성 화합물을포함하는 골다공증 예방 또는 치료용 조성물
    5.
    发明授权
    삼백초 추출물 또는 이로부터 분리된 활성 화합물을포함하는 골다공증 예방 또는 치료용 조성물 有权
    用于预防或治疗包含SAURURUS CHINENSIS或活性化合物提取物的OSTEOPOSOSIS的组合物,其分离

    公开(公告)号:KR100833654B1

    公开(公告)日:2008-05-29

    申请号:KR1020070013661

    申请日:2007-02-09

    CPC classification number: A61K36/78

    Abstract: A composition comprising the extract of Saururus chinensis or active compounds isolated therefrom is provided to inhibit growth of osteoclast, so that the composition is useful for preventing or treating osteoporosis. A composition for preventing or treating osteoporosis comprises 0.01-30 wt.% of the extract of Saururus chinensis, which is prepared by extracting Saururus chinensis with C1-4 alcohol and its solution, dichloromethane, ethylacetate or a mixture thereof, or active compounds isolated from the Saururus chinensis extract including (-)-saucerneol represented by the formula(1) and sauristolactam represented by the formula(2), and is a pharmaceutical or health food composition having a formulation of beverage.

    Abstract translation: 提供了包含中华黄牛提取物或从其分离的活性化合物的组合物以抑制破骨细胞的生长,使得该组合物可用于预防或治疗骨质疏松症。 用于预防或治疗骨质疏松症的组合物包括通过用C 1-4醇提取中华黄芪和其溶液,二氯甲烷,乙酸乙酯或其混合物或从其中分离的活性化合物制备的中华黄瓜提取物的0.01-30重量% 含有由式(1)表示的( - ) - 三氯蔗糖和由式(2)表示的沙拉耳内酰胺,是具有饮料配方的药物或保健食品组合物。

    카르바닐리드 유도체를 유효성분으로 포함하는 이상증식혈관 질환의 예방 또는 치료용 조성물
    7.
    发明公开
    카르바닐리드 유도체를 유효성분으로 포함하는 이상증식혈관 질환의 예방 또는 치료용 조성물 审中-实审
    用于预防或治疗包含作为活性成分的碳酰胺衍生物的高增殖性血管疾病的组合物

    公开(公告)号:KR1020160022318A

    公开(公告)日:2016-02-29

    申请号:KR1020160011793

    申请日:2016-01-29

    Abstract: 본발명은동맥경화증또는혈관협착증을비롯한이상증식혈관질환의예방또는치료용조성물에관한것이다. 본발명에서개시하는화합물은이상증식혈관질환의진행에핵심적인역할을하는혈관평활근세포의증식을크게억제함으로써동맥경화및 혈관협착증등의질환에대한효과적인치료제조성물로유용하게이용될수 있다.

    Abstract translation: 本发明涉及用于预防或治疗过度增殖性血管疾病如动脉粥样硬化或血管狭窄的组合物。 本发明公开的化合物可以通过显着抑制在进行过度增殖性血管疾病中发挥核心作用的血管平滑肌细胞的增殖而被有效地用作关于诸如动脉粥样硬化,血管狭窄等疾病的有效药物组合物 。

    골 관련 질환 치료용 조성물
    8.
    发明授权
    골 관련 질환 치료용 조성물 有权
    用于治疗骨相关疾病的组合物

    公开(公告)号:KR101594506B1

    公开(公告)日:2016-02-17

    申请号:KR1020140032886

    申请日:2014-03-20

    Abstract: 본발명은골 관련질환의예방또는치료용조성물에관한것이다. 본발명의화합물은조골세포의분화를효율적으로촉진함이다각적으로확인되었다. 따라서, 본발명의화합물을포함하는조성물은골 조직의형성및 회복을통해골 형성결핍및 골질감소에기인하는다양한골 관련질환의근본적인치료에유용하게이용될수 있다.

    콜치신 유도체를 유효성분으로 포함하는 암의 예방 또는 치료용 조성물
    9.
    发明公开
    콜치신 유도체를 유효성분으로 포함하는 암의 예방 또는 치료용 조성물 有权
    用于预防或治疗包含化合物衍生物的癌症的组合物

    公开(公告)号:KR1020140086355A

    公开(公告)日:2014-07-08

    申请号:KR1020120156713

    申请日:2012-12-28

    Abstract: The present invention relates to a novel colchicine derivative or a pharmaceutically acceptable salt thereof and to a composition for preventing or treating cancer comprising the same as an active ingredient. The novel colchicine derivative of the present invention significantly reduces the expression of polo-like kinase (Plk-1) and stimulates the apoptosis of cancer cells while markedly suppressing the growth of the cancer cells by activating p21 and p53, thereby being capable of being usefully applied to an effective treatment composition on various cancers.

    Abstract translation: 本发明涉及一种新的秋水仙素衍生物或其药学上可接受的盐,以及涉及用于预防或治疗癌症的组合物,其包含其作为活性成分。 本发明的新型秋水仙碱衍生物显着降低了polo样激酶(Plk-1)的表达,刺激癌细胞凋亡,同时通过激活p21和p53显着抑制癌细胞的生长,从而有效地 适用于各种癌症的有效治疗组合物。

Patent Agency Ranking